The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe allergic reactions. The FDA said Neffy needs more research.
Streaming Weeknights
Menu
You’ve reached the maximum number of streams allowed with your subscription.
To view this video, close the other videos you’re watching and try again.
The Food and Drug Administration on Tuesday declined to approve Neffy, an epinephrine nasal spray that offers a needle-free alternative for treating severe allergic reactions. The FDA said Neffy needs more research.
SUBSCRIBE
